Factor viii inhibitor bypassing activity

octaplasLG 45-70 mg/ml otopina za infuziju

otopina za infuzijuCroatiaMarketedAuthorised 10 Nov 2020

In other countries

The same active substances on other registers, the same brand first.

Feiba NFCanada · 3250 UNIT / VIAL · Kit, Powder For Solution · Takeda Canada INCSame substance
Feiba NFCanada · 1300 UNIT / VIAL · Kit, Powder For Solution · Takeda Canada INCSame substance
Feiba NFCanada · 650 UNIT / VIAL · Kit, Powder For Solution · Takeda Canada INCSame substance
FeibaItaly · Polvere e solvente per soluzione iniettabile · Baxalta Innovations GMBHSame substance
FEIBA 100 E/ml, poeder en oplosmiddel voor oplossing voor infusieNetherlands · Poeder en oplosmiddel voor oplossing voor infusie · Baxalta Innovations GmbHSame substance
FEIBA 25 U/mlRomania · 25U/ml · pulb+solv. pt. sol. perf. · Baxalta Innovations GMBHSame substance
FEIBA 50 U/mlRomania · 50U/ml · pulb+solv. pt. sol. perf. · Baxalta Innovations GMBH

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Factor viii inhibitor bypassing activity

octaplasLG 45-70 mg/ml otopina za infuziju

otopina za infuzijuCroatiaMarketedAuthorised 10 Nov 2020

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Feiba NFSerbia · 500j./20mL · prašak i rastvarač za rastvor za infuziju · Takeda DOO

Feiba 50U Powder&SolventSaudi Arabia · Takeda Manufacturing Austria AG

Feiba 50U Powder&SolventSaudi Arabia · Baxter AG

Feiba 1000 USingapore · 50 u/ml · injection, powder, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.

Feiba 500 USingapore · 25 u/ml · injection, powder, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.

Autoplex, Feiba Nf, Feiba VhUnited States · 500U · For Injection · Takeda Pharmaceuticals U.S.A., Inc.

Autoplex, Feiba Nf, Feiba VhUnited States · 1000U · For Injection · Takeda Pharmaceuticals U.S.A., Inc.

Autoplex, Feiba Nf, Feiba VhUnited States · 2500U · For Injection · Takeda Pharmaceuticals U.S.A., Inc.

Packs

Pack	Code	Status
1 vrećica s 200 ml otopine, u kutiji	HR-H-098600779-01	stavljeno u promet

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Factor viii inhibitor bypassing activity
Dosage form: otopina za infuziju
Register: Croatia (HALMED)
Status: Marketed
Status in the register: stavljeno u promet; nema nestašice
Authorised: 10 Nov 2020
Registration: HR-H-098600779
Marketing authorisation holder: Octapharma (IP) SPRL, Allee De La Recherche 65, Anderlecht, Belgija
Manufacturer: Octapharma AB, Stockholm, Švedska
ATC code: B05AA
Group: Blood and blood-forming organs
Procedure: National, MRP or DCP
Supply: na recept; u ljekarni

Croatia